Prostate Cancer
Recent Abstracts
EAU 2011 - Combining screening and chemoprevention of prostate cancer - Session Highlights
May 3, 2011
EAU 2011 - Results from the Gothenburg randomized prostate cancer screening trial - Session Highlights
May 3, 2011
The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers - Abstract
May 2, 2011
Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy - Abstract
May 2, 2011
Avoiding androgen deprivation therapy in men with high-risk prostate cancer: The role of radical prostatectomy as initial treatment - Abstract
May 2, 2011
Prostate cancer treatment ascertained from several sources: Analysis of disagreement and error - Abstract
May 2, 2011
Factors associated with downgrading in patients with high grade prostate cancer - Abstract
May 2, 2011
A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer - Abstract
May 2, 2011
Comorbidity and competing risks for mortality in men with prostate cancer - Abstract
May 2, 2011
Prostate cancer stem cells and their potential roles in metastasis - Abstract
May 2, 2011
A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study - Abstract
May 2, 2011
Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins - Abstract
May 2, 2011
Contemporary management of postprostatectomy incontinence - Abstract
May 2, 2011
EAU 2011 - Antibiotics and/or alpha blocker agents may decrease the PSA levels before biopsy but not detection rate of prostate cancer - Session Highlights
May 2, 2011
EAU 2011 - Metabolic syndrome and prostate cancer: A possible link to prostate cancer aggressiveness - Session Highlights
May 2, 2011
EAU 2011 - Periprostatic fat pads harbor lymph nodes and lymph node metastases: Impact on pathological work up - Session Highlights
May 1, 2011
PROVENGE (sipuleucel-T) in prostate cancer: The first FDA approved therapeutic cancer vaccine - Abstract
April 29, 2011
Drug development for metastatic castration-resistant prostate cancer: Current status and future perspectives - Abstract
April 29, 2011
Emerging novel therapies in the treatment of castrate-resistant prostate cancer - Abstract
April 29, 2011
The impact of clinical factors on the development of late radiation toxicity: Results from the Medical Research Council RT01 Trial (ISRCTN47772397) - Abstract
April 29, 2011
Page 1420 of 1450
Start
Prev
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free